Invention Grant
- Patent Title: Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
-
Application No.: US17848694Application Date: 2022-06-24
-
Publication No.: US11952429B2Publication Date: 2024-04-09
- Inventor: J. Andrew Bristol , Judith A. Kantor
- Applicant: PRECISION BIOLOGICS, INC.
- Applicant Address: US MD Bethesda
- Assignee: PRECISION BIOLOGICS, INC.
- Current Assignee: PRECISION BIOLOGICS, INC.
- Current Assignee Address: US MD Bethesda
- Agency: Baker, Donelson, Bearman, Caldwell & Berkowitz PC
- Agent Robin L. Teskin
- The original application number of the division: US16796572 2020.02.20
- Main IPC: A61K45/06
- IPC: A61K45/06 ; A61K39/395 ; A61K47/68 ; C07K16/18 ; C07K16/30 ; G01N33/574 ; G01N33/577 ; A61K39/00
Abstract:
The present invention provides for recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens, along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to the nucleic acids, and uses for these antibodies, nucleic acids and amino acids.
Public/Granted literature
- US20220403045A1 RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS Public/Granted day:2022-12-22
Information query
